Survival as a function of HBA1c in people with type 2 diabetes

The Lancet

Volumn 375, Issue 9724, 2010, Pages 1434-1435

  Cruickshank, J Kennedy ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

ADIPOCYTE; CAUSE OF DEATH; CELL DIVISION; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; LETTER; LIPID STORAGE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SIDE EFFECT; SURVIVAL; VASCULAR DISEASE; WEIGHT GAIN; BLOOD; MORTALITY; NOTE; TIME;

DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 77952296999     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)60616-2     Document Type: Letter

References (5)

1. 1c in people with type 2 diabetes: a retrospective cohort study. Lancet 2010;375:481-89.
2. 1c. Lancet 2010;375:438-40.
3. Retnakaran R, Shah BR. Mild glucose intolerance in pregnancy and risk of cardiovascular disease: a population-based cohort study. Can Med Assoc J 2009;181:371-76.
4. Greenstein AS, Khavandi K, Withers SB, et al. Local infl ammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation 2009;119:1661-70.
5. Cruickshank JK. Low-dose thiazide diuretics in and around diabetes-defi nitely yes, and how do they compare with other interventions? Diabetic Med 2010;27:127-29.